Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories
-
AIM Stockholder Full Value Committee Announces Director Nominations for AIM Annual Meeting and Confirms Intent to Proceed with Proxy Solicitation
-
VBL Therapeutics (VBLT) Appoints Alison Finger and Michael Rice to its Board of Directors
-
VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors
-
MICT, Inc. Welcomes Robert Benton to Its Board of Directors; John Scott to Assume Role of Non-Executive Deputy Chairman
-
MICT, Inc. Welcomes Robert Benton to Its Board of Directors; John Scott to Assume Role of Non-Executive Deputy Chairman
-
9 Meters Biopharma (NMTR) Appoints Michael Rice to Board of Directors
-
9 Meters Biopharma, Inc. Appoints Michael Rice to Board of Directors
-
Giyani Appoints Robin Birchall as CEO and Director and Grants Stock Options
-
LifeSci Advisors Expands Corporate Access Team with Addition of Frank Gaul
-
RDD Pharma Appoints Michael Rice to Board of Directors
-
GreenCoinX Forms Advisory Board
-
Deciphera Pharmaceuticals Appoints Tucker Kelly as Chief Financial Officer
-
Here's Everything You Need to Know About Apple's (AAPL) Nearly $100 Billion Cash Hoard
-
Wall Street Saddened By Apple (AAPL) Jobs News, But Says the Show Will Go On
-
Canaccord Adams Sees Protalix BioTherapeutics (PLX) FDA Approval Early
-
A Thorough Breakdown of Netflix's (NFLX) Outstanding Fourth Quarter
-
Apple (AAPL) Analysts Widely Miss Mark on iPad in 2010
-
Unusual 11 Mid-Day Movers 08/12: LQMT, GAGC, AAU, GLOI, REDF, FOLD Higher; VRML, ICOP, ANW, NPD, SIHI Lower
-
IBM (IBM) Looks for Solid Q2 Results on IT, Enterprise Spending (ORCL, INTC)
-
Research In Motion (RIMM) Shares Trading Higher Ahead of Tomorrow's Q1 Results
-
Notable Analyst Rating Changes 06/09: EQIX, POT, BTU, VALE Upgraded; EVVV, RST, FFIV, WTNY Downgraded
-
Notable 52-Week High's and Low's of the Day 06/02: GNA, LCC, PANL, XEC High; NVGN, FAF, RIG, GAME Low
-
Canaccord Adams Maintains a 'Buy' on DexCom (DXCM); Weakness on FDA Warning Letter Presents Buying Opportunity
-
Canaccord Adams Changes Rating on ev3 (EVVV) to Tender
-
Canaccord Adams Maintains a 'Buy' on Casella Waste Systems (CWST); April Quarter Results Preview
-
Canaccord Adams Reiterates a 'Buy' on Foster Wheeler (FWLT); After Adjusting for Euro Exposure a Compelling Story Remains
-
Canaccord Adams Maintains a 'Hold' on Cyberonics (CYBX); FQ4/10 Preview: Expect Positive News on Japanese Reimbursement
-
Canaccord Adams Maintains a 'Buy' on FuelCell Energy (FCEL); Q2/10 preview
-
UPDATE - Canaccord Adams Upgrades Universal Display (PANL) to Buy; A Bright SID Conference Highlights OLED Ramp
-
Unusual 11 Mid-Day Movers 06/01: EVVV, JSDA, MCCC, WH, PANL, PBTH Up; MSHL, WMG, TTI Down
-
Morning Movers 6/1: EVVV, MCCC, PANL, HEV, PUK Higher; APC, WMG, BP, BEAT, DRQ, ATPG Lower
-
Canaccord Adams Upgrades Universal Display (PANL) to Buy
-
Canaccord Adams Maintains a 'Buy' Rating on Royal Bank of Canada (RY), Reducing Estimates and Grget Price
-
Canaccord Adams Reiterates a 'Hold' on OmniVision (OVTI); Megapixel Upgrade Driving Significant Upside
-
Canaccord Adams Reiterates a 'Buy' on Magma Design Automation (LAVA); Product Cycle and Improved Balance Sheet
-
Canaccord Adams Upgrades Triangle Petroleum (TPLM) to Speculative Buy
-
Canaccord Adams Maintains a 'Buy' on Schnitzer Steel Industries (SCHN); Positive Comments From The Road
-
Canaccord Adams Maintains a 'BUY/Best Idea' on NCI Building Systems (NCS); April Quarter Results Preview
-
Canaccord Adams Maintains a 'Buy' On Telvent GIT, S.A. (TLVT); Q1 Is OK, More Work To Be Done
-
Canaccord Adams Maintains a 'Buy' on Martek Biosciences (MATK); Big Pipeline, but Recurring Guidance Hurdle Next Week
-
Canaccord Adams Maintains a 'Hold' on Bank of Montreal (BMO); Credit and NIM Much Better Than Expected
-
Canaccord Adams Reiterates a 'Hold' on Semtech (SMTC); Data Points Grow Murkier
-
Canaccord Adams Maintains a 'Hold' on NetApp (NTAP); Best Execution in the Group; Europe Still Has Us Guarded
-
Canaccord Adams Maintains a 'Buy' on BPZ Energy (BPZ); New Start Date for Commercialization at Corvina
-
Canaccord Adams Maintains a 'Buy' on Avanir Pharmaceuticals (AVNR); APA Data Underscores Zenvia's Good Safety, Market Potential
-
Canaccord Adams Updates Ratings on Energy -- Oil and Gas, Exploration and Production Stocks
-
Canaccord Adams Upgrades Sims Metal Management (SMS) to Buy; Seizing The Opportunity
-
Canaccord Adams Reiterates a 'Hold' on Exelixis (EXEL); XL184 Clinical Data Reported
-
Canaccord Adams Maintains a 'Hold' Brocade Communications (BRCD); Some Puts, Some Takes; Predictability Still the Challenge
-
Canaccord Adams Maintains a 'Hold' on Raven Industries (RAVN); Raises PT

